112 related articles for article (PubMed ID: 32384116)
1. Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus.
Choi JH; Woo HM; Lee TY; Lee SY; Shim SM; Park WJ; Yang JS; Kim JA; Yun MR; Kim DW; Kim SS; Zhang Y; Shi W; Wang L; Graham BS; Mascola JR; Wang N; McLellan JS; Lee JY; Lee H
PLoS One; 2020; 15(5):e0232757. PubMed ID: 32384116
[TBL] [Abstract][Full Text] [Related]
2. Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape.
Wang L; Shi W; Chappell JD; Joyce MG; Zhang Y; Kanekiyo M; Becker MM; van Doremalen N; Fischer R; Wang N; Corbett KS; Choe M; Mason RD; Van Galen JG; Zhou T; Saunders KO; Tatti KM; Haynes LM; Kwong PD; Modjarrad K; Kong WP; McLellan JS; Denison MR; Munster VJ; Mascola JR; Graham BS
J Virol; 2018 May; 92(10):. PubMed ID: 29514901
[TBL] [Abstract][Full Text] [Related]
3. A dual-targeting approach using a human bispecific antibody against the receptor-binding domain of the Middle East Respiratory Syndrome Coronavirus.
Lee JH; Kim JW; Lee HE; Song JY; Cho AH; Hwang JH; Heo K; Lee S
Virus Res; 2024 Jul; 345():199383. PubMed ID: 38697296
[TBL] [Abstract][Full Text] [Related]
4. Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.
Ying T; Du L; Ju TW; Prabakaran P; Lau CC; Lu L; Liu Q; Wang L; Feng Y; Wang Y; Zheng BJ; Yuen KY; Jiang S; Dimitrov DS
J Virol; 2014 Jul; 88(14):7796-805. PubMed ID: 24789777
[TBL] [Abstract][Full Text] [Related]
5. MERS Vaccine Candidate Offers Promise, but Questions Remain.
Menachery VD
EBioMedicine; 2015 Oct; 2(10):1292-3. PubMed ID: 26629514
[No Abstract] [Full Text] [Related]
6. Stabilized coronavirus spike stem elicits a broadly protective antibody.
Hsieh CL; Werner AP; Leist SR; Stevens LJ; Falconer E; Goldsmith JA; Chou CW; Abiona OM; West A; Westendorf K; Muthuraman K; Fritch EJ; Dinnon KH; Schäfer A; Denison MR; Chappell JD; Baric RS; Graham BS; Corbett KS; McLellan JS
Cell Rep; 2021 Nov; 37(5):109929. PubMed ID: 34710354
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.
Pallesen J; Wang N; Corbett KS; Wrapp D; Kirchdoerfer RN; Turner HL; Cottrell CA; Becker MM; Wang L; Shi W; Kong WP; Andres EL; Kettenbach AN; Denison MR; Chappell JD; Graham BS; Ward AB; McLellan JS
Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7348-E7357. PubMed ID: 28807998
[TBL] [Abstract][Full Text] [Related]
8. Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex.
Park BK; Maharjan S; Lee SI; Kim J; Bae JY; Park MS; Kwon HJ
BMB Rep; 2019 Jun; 52(6):397-402. PubMed ID: 30355437
[TBL] [Abstract][Full Text] [Related]
9. Nucleic acid vaccine candidates encapsulated with mesoporous silica nanoparticles against MERS-CoV.
Almansour I; Jermy BR
Hum Vaccin Immunother; 2024 Dec; 20(1):2346390. PubMed ID: 38691025
[TBL] [Abstract][Full Text] [Related]
10. Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease.
Tao X; Garron T; Agrawal AS; Algaissi A; Peng BH; Wakamiya M; Chan TS; Lu L; Du L; Jiang S; Couch RB; Tseng CT
J Virol; 2016 Jan; 90(1):57-67. PubMed ID: 26446606
[TBL] [Abstract][Full Text] [Related]
11. Characterization and immunogenicity assessment of MERS-CoV pre-fusion spike trimeric oligomers as vaccine immunogen.
Ahuja R; Vishwakarma P; Raj S; Kumar V; Khatri R; Lohiya B; Saxena S; Kaur G; Singh G; Asthana S; Ahmed S; Samal S
Hum Vaccin Immunother; 2024 Dec; 20(1):2351664. PubMed ID: 38757508
[TBL] [Abstract][Full Text] [Related]
12. CD26/DPP4 cell-surface expression in bat cells correlates with bat cell susceptibility to Middle East respiratory syndrome coronavirus (MERS-CoV) infection and evolution of persistent infection.
Caì Y; Yú SQ; Postnikova EN; Mazur S; Bernbaum JG; Burk R; Zhāng T; Radoshitzky SR; Müller MA; Jordan I; Bollinger L; Hensley LE; Jahrling PB; Kuhn JH
PLoS One; 2014; 9(11):e112060. PubMed ID: 25409519
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody.
Ohnuma K; Haagmans BL; Hatano R; Raj VS; Mou H; Iwata S; Dang NH; Bosch BJ; Morimoto C
J Virol; 2013 Dec; 87(24):13892-9. PubMed ID: 24067970
[TBL] [Abstract][Full Text] [Related]
14. Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein.
Xia S; Liu Q; Wang Q; Sun Z; Su S; Du L; Ying T; Lu L; Jiang S
Virus Res; 2014 Dec; 194():200-10. PubMed ID: 25451066
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgenera.
Hutchinson GB; Abiona OM; Ziwawo CT; Werner AP; Ellis D; Tsybovsky Y; Leist SR; Palandjian C; West A; Fritch EJ; Wang N; Wrapp D; Boyoglu-Barnum S; Ueda G; Baker D; Kanekiyo M; McLellan JS; Baric RS; King NP; Graham BS; Corbett-Helaire KS
Nat Commun; 2023 Oct; 14(1):6195. PubMed ID: 37794071
[TBL] [Abstract][Full Text] [Related]
16. A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques.
van Doremalen N; Haddock E; Feldmann F; Meade-White K; Bushmaker T; Fischer RJ; Okumura A; Hanley PW; Saturday G; Edwards NJ; Clark MHA; Lambe T; Gilbert SC; Munster VJ
Sci Adv; 2020 Jun; 6(24):eaba8399. PubMed ID: 32577525
[TBL] [Abstract][Full Text] [Related]
17. Molecular insights on the coronavirus MERS-CoV interaction with the CD26 receptor.
Failayev H; Ganoth A; Tsfadia Y
Virus Res; 2024 Apr; 342():199330. PubMed ID: 38272241
[TBL] [Abstract][Full Text] [Related]
18. A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus.
Tse LV; Hou YJ; McFadden E; Lee RE; Scobey TD; Leist SR; Martinez DR; Meganck RM; Schäfer A; Yount BL; Mascenik T; Powers JM; Randell SH; Zhang Y; Wang L; Mascola J; McLellan JS; Baric RS
Sci Transl Med; 2023 Sep; 15(715):eadg5567. PubMed ID: 37756379
[TBL] [Abstract][Full Text] [Related]
19. Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control.
Durai P; Batool M; Shah M; Choi S
Exp Mol Med; 2015 Aug; 47(8):e181. PubMed ID: 26315600
[TBL] [Abstract][Full Text] [Related]
20. Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV.
Chao CW; Sprouse KR; Miranda MC; Catanzaro NJ; Hubbard ML; Addetia A; Stewart C; Brown JT; Dosey A; Valdez A; Ravichandran R; Hendricks GG; Ahlrichs M; Dobbins C; Hand A; Treichel C; Willoughby I; Walls AC; McGuire AT; Leaf EM; Baric RS; Schäfer A; Veesler D; King NP
bioRxiv; 2024 Mar; ():. PubMed ID: 38558973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
